Compare · CVR vs TMO
CVR vs TMO
Side-by-side comparison of Chicago Rivet & Machine Co. (CVR) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CVR and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $250.83B, about 25329.6x CVR ($9.9M).
- Over the past year, CVR is down 1.2% and TMO is up 45.3% - TMO leads by 46.6 points.
- TMO has hit the wire 11 times in the past 4 weeks while CVR has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 0 for CVR).
- Company
- Chicago Rivet & Machine Co.
- Thermo Fisher Scientific Inc
- Price
- $10.20-1.88%
- $674.65-0.58%
- Market cap
- $9.9M
- $250.83B
- 1M return
- -1.88%
- +6.42%
- 1Y return
- -1.21%
- +45.34%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- AMEX
- NYSE
- IPO
- 1930
- News (4w)
- 0
- 11
- Recent ratings
- 0
- 25
Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co. operates in the fastener industry in North America. It operates in two segments, Fasteners and Assembly Equipment. The Fastener segment manufactures and sells rivets, cold-formed fasteners and parts, and screw machine products. The Assembly Equipment segment manufactures automatic rivet setting machines and assembly equipment, as well as parts and tools for related machines. The company sells its products to automobile and automotive component manufacturers through independent sales representatives. Chicago Rivet & Machine Co. was founded in 1920 and is headquartered in Naperville, Illinois.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest CVR
- Chicago Rivet & Machine Co. Announces Second Quarter Results of Operations
- SEC Form 10-Q filed by Chicago Rivet & Machine Co.
- CHICAGO RIVET & MACHINE CO. ANNOUNCES REBRANDING AND NEW CORPORATE IDENTITY
- Director Cooney Kent H bought $8,865 worth of shares (900 units at $9.85), increasing direct ownership by 900% to 1,000 units (SEC Form 4)
- Chicago Rivet & Machine Co. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
- CHICAGO RIVET & MACHINE CO. ANNOUNCES TEMPORARY SUSPENSION OF QUARTERLY DIVIDEND
- SEC Form SD filed by Chicago Rivet & Machine Co.
- Chicago Rivet & Machine Co. Announces First Quarter Results of Operations
- SEC Form 10-Q filed by Chicago Rivet & Machine Co.
- Chicago Rivet & Machine Co. Announces Year-End Results of Operations
Latest TMO
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)
- SVP and General Counsel Shropshire Thomas B Jr. covered exercise/tax liability with 49 shares, decreasing direct ownership by 0.81% to 6,008 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. covered exercise/tax liability with 394 shares, decreasing direct ownership by 3% to 14,391 units (SEC Form 4)
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 270 shares, decreasing direct ownership by 5% to 5,560 units (SEC Form 4)
- Chairman & CEO Casper Marc N covered exercise/tax liability with 1,257 shares, decreasing direct ownership by 1% to 122,669 units (SEC Form 4)
- VP & Chief Accounting Officer Holmes Joseph R. covered exercise/tax liability with 50 shares, decreasing direct ownership by 2% to 2,916 units (SEC Form 4)
- President & COO Pettiti Gianluca covered exercise/tax liability with 1,035 shares, sold $2,539,233 worth of shares (4,133 units at $614.38) as part of a pre-agreed trading plan and exercised 3,733 shares at a strike of $309.63, decreasing direct ownership by 6% to 23,216 units (SEC Form 4)